...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Possible Involvement ofµOpioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats
【24h】

Possible Involvement ofµOpioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats

机译:μopioid受体在舒宇式在抑制应激诱导的抑郁症状大鼠中的抗抑郁效果中的可能参与

获取原文
           

摘要

Recentlyμopioid receptor (MOR) has been shown to be closely associated with depression. Here we investigated the action of Shuyu, a Chinese herbal prescription, on repeated restraint stress induced depression-like rats, with specific attention to the role of MOR and the related signal cascade. Our results showed that repeated restraint stress caused significant depressive-like behaviors, as evidenced by reduced body weight gain, prolonged duration of immobility in forced swimming test, and decreased number of square-crossings and rearings in open field test. The stress-induced depression-like behaviors were relieved by Shuyu, which was accompanied by decreased expression of MOR in hippocampus. Furthermore, Shuyu upregulated BDNF protein expression, restored the activity of CREB, and stimulated MEK and ERK phosphorylation in hippocampus of stressed rats. More importantly, MOR is involved in the effects of Shuyu on these depression-related signals, as they can be strengthened by MOR antagonist CTAP. Collectively, these data indicated that the antidepressant-like properties of Shuyu are associated with MOR and the corresponding CREB, BDNF, MEK, and ERK signal pathway. Our study supports clinical use of Shuyu as an effective treatment of depression and also suggests that MOR might be a target for treatment of depression and developing novel antidepressants.
机译:最近的致致酸受体(Mor)已被证明与抑郁症密切相关。在这里,我们调查了舒宇,中草药处方的作用,反复抑制应激诱发抑郁症状的大鼠,特别关注MOR和相关信号级联的作用。我们的研究结果表明,反复抑制应力引起了显着的抑郁型行为,如减少体重增加,延长了强迫游泳试验中的不动的持续时间,并降低了开场测试中的方形交叉数量和饲养。舒宇缓解了应激诱导的抑郁症行为,伴随着海马的Mor表达下降。此外,水宇上调的BDNF蛋白表达,恢复了CREB的活性,并在压力大鼠的海马中刺激了MEK和ERK磷酸化。更重要的是,Mor参与了舒宇对这些与抑郁相关信号的影响,因为他们可以通过Mor拮抗剂CTAP加强。总的来说,这些数据表明,舒苏的抗抑郁性质与MOR和相应的CREB,BDNF,MEK和ERK信号通路相关联。我们的研究支持舒苏的临床应用作为抑郁症的有效治疗,也表明Mor可能是治疗抑郁症和开发新型抗抑郁药的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号